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The human immunodeficiency virus type 1 (HIV-1) unspliced, 9 kb genomic RNA (vRNA)
is exported from the nucleus for the synthesis of viral structural proteins and enzymes
(Gag and Gag/Pol) and is then transported to sites of virus assembly where it is pack-
aged into progeny virions. vRNA co-exists in the cytoplasm in the context of the HIV-1
ribonucleoprotein (RNP) that is currently defined by the presence of Gag and several host
proteins including the double-stranded RNA-binding protein, Staufen1. In this study we iso-
lated Staufen1 RNP complexes derived from HIV-1-expressing cells using tandem affinity
purification and have identified multiple host protein components by mass spectrometry.
Four viral proteins, including Gag, Gag/Pol, Env and Nef as well as >200 host proteins
were identified in these RNPs. Moreover, HIV-1 induces both qualitative and quantitative
differences in host protein content in these RNPs. 22% of Staufen1-associated factors are
virion-associated suggesting that the RNP could be a vehicle to achieve this. In addition, we
provide evidence on how HIV-1 modulates the composition of cytoplasmic Staufen1 RNPs.
Biochemical fractionation by density gradient analyses revealed new facets on the assem-
bly of Staufen1 RNPs.The assembly of dense Staufen1 RNPs that contain Gag and several
host proteins were found to be entirely RNA-dependent but their assembly appeared to
be independent of Gag expression. Gag-containing complexes fractionated into a lighter
and another, more dense pool. Lastly, Staufen1 depletion studies demonstrated that the
previously characterized Staufen1 HIV-1-dependent RNPs are most likely aggregates of
smaller RNPs that accumulate at juxtanuclear domains. The molecular characterization of
Staufen1 HIV-1 RNPs will offer important information on virus-host cell interactions and on
the elucidation of the function of these RNPs for the transport of Gag and the fate of the
unspliced vRNA in HIV-1-producing cells.
Keywords: Gag, genomic RNA, HIV-1, mass spectrometry, gradient centrifugation, ribonucleoprotein, Staufen1,
virus-host interactions
INTRODUCTION
HIV-1 infection is characterized by a progressive depletion of
CD4+T lymphocytes that makes patients susceptible to oppor-
tunistic diseases and ultimately leads to the development of
acquired immunodeficiency syndrome (AIDS; Ho et al., 1995;
Lindwasser et al., 2007). HIV-1 replication is divided into early
and late events (Wang et al., 2000; Freed, 2001): the early events
include virus entry, uncoating of the viral core that contains
the vRNA, reverse transcription of vRNA to cDNA and finally,
the integration of the resulting viral double-stranded DNA into
host chromosomes. The later events include the transcription
of the proviral genome to generate a primary transcript, the
vRNA, its processing, maturation and nucleocytoplasmic export
and also the synthesis of viral structural proteins, virus assembly
and budding. Following transcription, the vRNA either remains
unspliced or is spliced to generate more than 30 distinct mRNAs
that are grouped into singly spliced, 4 kb mRNAs (encoding the
auxiliary proteins Vif, Vpr, Vpu and the glycoprotein, Env) or
into multiply spliced, 1.8 kb mRNA species (encoding the early
viral regulatory proteins Tat, Rev and Nef; Arrigo et al., 1990;
Schwartz et al., 1990; Purcell and Martin, 1993). The 1.8 kb
RNAs are constitutively exported from the nucleus early fol-
lowing transcription, while the nuclear export of vRNA and
the 4 kb species is dependent on the CRM1/Exportin1 export
pathway (Yi et al., 2002). These events are well orchestrated,
dynamic and depend on the activities of viral as well as select
host cell proteins and machineries that are co-opted by the
virus.
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The two largest viral mRNA species, which contain intronic
sequences, are both exported from the nucleus and translated in
the cytoplasm. While usually mRNAs with introns are tagged as
aberrant since they are “incompletely spliced” and are degraded
by cellular RNA quality control machineries (Doma and Parker,
2007), these viral mRNAs are quite stable (Mouland et al., 2002),
and therefore likely evade this surveillance machinery by co-
opting host proteins involved in this process (Ajamian et al.,
2008; Nathans et al., 2009). Furthermore, vRNA has an addi-
tional fate in that it can also be packaged into progeny virions
(Butsch and Boris-Lawrie, 2002). This latter step is made possi-
ble by a selective interaction between vRNA and its gene prod-
uct, the precursor Group specific antigen, pr55Gag (termed Gag
herein). Gag interacts with a packaging signal in the 5′UTR of
vRNA for selection into assembling virions (Lever et al., 1989;
Clever et al., 1995). Like other mRNAs, vRNA is likely trans-
ported through the cytoplasm in the context of an RNP (Wil-
helm and Vale, 1993; Mouland et al., 2001; Lehmann et al.,
2009). Indeed, mRNA-binding proteins such as Staufen1 asso-
ciate closely with Gag to form the HIV-1 RNP that also incor-
porates vRNA, but none of the spliced HIV-1 RNAs (Chatel-
Chaix et al., 2004; Cochrane et al., 2006). Moreover, recent work
has demonstrated that HIV-1 RNPs that contain Staufen1 take
advantage of endosomal machineries for intracellular trafficking
(Lehmann et al., 2009; Molle et al., 2009). Nevertheless, these later
events still remain one of the most understudied areas of HIV-1
biology.
Generally, like other cellular RNPs, the composition of cytoso-
lic HIV-1 RNPs is plastic in nature such that proteins may engage
in the nucleus, disengage and/or be acquired during transit from
the nucleus to the cytoplasm and during the assembly of vRNA
into viral particles. The composition of the HIV-1 RNP has not
been completely characterized, however. Recent work supports
the idea that vRNA interacts with Gag at juxtanuclear and cyto-
plasmic domains (Poole et al., 2005; Levesque et al., 2006) and
considerable efforts are now being made to evaluate how HIV-1
co-opts factors following the nuclear export of the vRNA – a late
step in HIV-1 replication that includes RNA transport, utilization
(translation) and degradation (Cochrane et al., 2006; Lehmann
et al., 2009; Molle et al., 2009; Kemler et al., 2010). The forma-
tion of the HIV-1 RNP is initially achieved by the binding of Gag
via its nucleocapsid (NC) domain and the RNA packaging sig-
nal psi in the 5′-end of the vRNA. This early capture may govern
the directed movement of vRNA along the cytoskeleton, to the
translation apparatus, to sites of viral assembly and finally, into
assembling viral particles. A number of host gene products, such
as hnRNP A1, PSF/nsr54 and APOBEC3G associate with vRNA
(Beriault et al., 2004; Khan et al., 2005). Furthermore, a limited
set of host trans-acting proteins mediates trafficking by binding
to specific cis-acting sequence elements in vRNA (Mouland et al.,
2001; Levesque et al., 2006). While the stability and functionality
of HIV-1 RNP is most probably a result of interactions between
a few viral (i.e., Gag) and host cell proteins such as Staufen1 and
Upf1 (Up-frameshift protein 1; Chatel-Chaix et al., 2004; Ajamian
et al., 2008), the molecular composition of the HIV-1 RNP likely
changes and is dictated by HIV-1, either by direct recruitment of,
or by binding to host cell factors.
Staufen1 belongs to a growing family of the double-stranded
RNA-binding proteins (dsRBPs) that includes protein kinase
dsRNA dependent (PKR), the activator of PKR (PACT), TAR-RNA
binding protein (TRBP) and RNA Helicase A (RHA, reviewed in
(Fierro-Monti and Mathews, 2000; Saunders and Barber, 2003;
Tian et al., 2004) and is a principal component of various RNPs
that are engaged in the localization and trafficking of cellular
mRNAs (Kiebler et al., 1999; Kiebler and DesGroseillers, 2000;
Roegiers and Jan, 2000). Staufen1-containing high-molecular
weight complexes ranging in size from 10–30 MDa appear as gran-
ules dispersed in the cytoplasm of eukaryotic cells. Several com-
ponents are found in these complexes such as ribosomes, tubulin,
actin, dynein, RHA, hnRNP U and nucleolin (Brendel et al., 2004;
Villace et al., 2004). RNA-binding by Staufen1 regulates diverse
classes of mammalian mRNAs that encode proteins with func-
tions in different metabolic pathways and cellular physiological
processes (Kim et al., 2007; Furic et al., 2008).
Our previous work demonstrated that Staufen1 binds to both
Gag as well as its vRNA substrate (while excluding all of the spliced
HIV-1 RNA species), which likely drives the incorporation of Gag
and vRNA into assembling virions through the formation of a
HIV-1 RNP (Mouland et al., 2000; Chatel-Chaix et al., 2004).
Furthermore, modulating the levels of Staufen1, by siRNAs and
overexpression, perturbs HIV-1 assembly, including Gag multi-
merization and vRNA encapsidation, resulting in negative effects
on viral infectivity (Mouland et al., 2000; Chatel-Chaix et al., 2004,
2007, 2008; Abrahamyan et al., 2010). Staufen1 also influences the
anterograde trafficking of Gag. Both Staufen1 and Gag were shown
to associate in the cytoplasm and also at cholesterol-enriched lipid
rafts, which are virus assembly domains (Milev et al., 2010).
Staufen1 potentially may play similar roles in the replication
of other retroviruses, such as, HIV-2 and MLV since it was found
incorporated within them (Mouland et al., 2000). Importantly it
does not associate with any tested DNA virus, including aden-
ovirus, Epstein-Barr virus and human herpesvirus 6, supporting
its preferential role in the biology of RNA viruses. In a yeast two-
hybrid screen and in co-immunoprecipitation (IP) experiments,
Staufen1 was identified as an interactive partner of the influenza
A virus non-structural protein, NS1 (Falcon et al., 1999). Recent
work demonstrated that Staufen1 also associates to viral RNPs
and viral RNAs in influenza virus-infected cells (de Lucas et al.,
2010). Staufen1 also associates with the 3′UTR of HCV RNA, the
sequence essential for the initiation of (−) strand synthesis (Harris
et al., 2006). Together with the numerous other cellular proteins
found to interact with this region, Staufen1 most probably also
plays a role in HCV replication.
The aim of the work described here was to examine the com-
position of the Staufen1 RNP proteome and how it is modulated
by HIV-1. To do this, Staufen1-binding proteins were purified
using tandem affinity purification (TAP) in HIV-1-expressing cells
and identified by mass spectrometry. Approximately 200 host pro-
teins were identified using this strategy. The Staufen1 HIV-1 RNP
that bound precursor Gag shared many proteins with cytosolic
RNA trafficking RNPs. However, notable compositional differ-
ences of the Staufen1 RNPs were induced by HIV-1. Furthermore,
∼22% of the identified proteins are found in isolated HIV-1 par-
ticles. Biochemical and imaging analyses confirmed many of these
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associations. Biochemical fractionation of cellular RNPs revealed
further characteristics of the Staufen1 RNPs that are assembled in
HIV-1-producing cells. Our results provide a comprehensive view
on the composition of Staufen1-containing HIV-1 RNPs and their
functional importance that likely resides in the fate of the vRNA.
MATERIALS AND METHODS
CELLS AND CELL LINES
Human embryonic kidney 293T cells HeLa, and Jurkat T cells were
maintained at 37˚C in Dulbecco’s modified Eagle’s or RPMI-1640
medium supplemented with 10% decomplemented fetal bovine
serum (FBS) and 100 U/ml penicillin, 100 mg/ml streptomycin
(Invitrogen). Stable TAP and Staufen1-TAP neomycin-resistant
cell lines were generated in 293T and Jurkat T cells. Briefly, 293T
cell were plated in 60 mm dishes and Jurkat T cells in 25 cm2
flasks. The following day these were transfected with 2 and 4µg
plasmid DNA, respectively, using Lipofectamine 2000 accord-
ing to the protocol provided by the manufacturer (Invitrogen).
24 h post-transfection, 600µg/ml G418 (Invitrogen) was added
to the medium for selection. The cell cultures were maintained
at 90% confluence and subsequently, sub-cultured at lower den-
sities. Resistant clones were isolated 14 days following selection.
Tissue culture medium was removed from the plates, and cells were
washed with sterile PBS. To pick colonies, sterile 3 mm cloning
disks were dipped in trypsin solution and placed on colonies for
30 s. The colonies adhered to the cloning disks and were trans-
ferred to 24-well dishes. When the cells reached pre-confluence,
they were transferred to 6-well plates. For suspension Jurkat T
cells, the procedure for isolation of stable clones differed as fol-
lows: cells were maintained in RPMI-1640 with 600µg/ml G418
for 14 days and then were serially diluted and transferred in 24-well
dishes for expansion. The surviving stable lines exhibited various
expression levels of the TAP tagged Staufen1 as assessed by SDS-
PAGE and western blotting. Staufen1-TAP expression levels were
constant for each clone and were stable for at least 20 subsequent
passages.
TRANSIENT TRANSFECTIONS
For affinity purification experiments, transfection of control TAP
and Staufen1-TAP stable cell lines with proviral DNA, pNL4-3,
was carried out in 150 cm2 flasks (Nunc). The cells were plated
at 5× 106 per flask for 24 h before transfection. 20µg of plasmid
and 50µl Lipofectamine per flask were added, cells were incu-
bated for 20 min and then mixed with tissue culture medium.
For IP analyses, HeLa cells were transfected with correspond-
ing amounts of plasmid DNA and cell lysates were prepared as
described previously (Mouland et al., 2000; Chatel-Chaix et al.,
2004). The overexpression of IMP1 (in the context of IMP1-VenC
fusion protein) was performed in both HeLa and 293T cells. Trans-
fection efficiencies were greater than 65% in all experiments (range
65–80%).
Staufen1-HA, pNL4-3 and pNL4-XX and transfection of HeLa
cells were described previously (Mouland et al., 2000; Chatel-
Chaix et al., 2004; Ajamian et al., 2008). For sucrose gradient
fractionation experiments, transfection of proviral DNA, pNL4-3
was carried out in 75 cm2 flasks (Nunc). The cells were plated
at 3× 106 per flask for 12 h before transfection. Transfection
efficiencies were greater than 70% in all experiments (range 65–
80%). For RNase A treatments, cell lysates were incubated for
30 min at 4˚C with RNase T1 at 1 U/mL. HeLa cells were trans-
fected with either non-silencing siRNA (siNS) or Staufen1 siRNA
(siStaufen1) at a final concentration of 10 nM. siRNA transfec-
tions were performed with lipofectamine 2000. Thirty-six hours
later, the cells were washed with ice cold PBS and lysed in XB
buffer for subcellular fractionation in sucrose gradients (see below;
Chatel-Chaix et al., 2004).
TANDEM AFFINITY PURIFICATION ANDWESTERN BLOTTING
The purification of Staufen1 complexes was adapted using the TAP
protocols as described previously (Puig et al., 2001; Villace et al.,
2004). Briefly, after transfection, cells were lysed in buffer (50 mM
Tris-HCl pH 7.5, 5 mM EDTA, 100 mM NaCl, 1 mM DTT, 0.5%
NP-40) and complete protease inhibitor cocktail (Roche). Cell
extracts were centrifuged at 4ºC for 5 min at 5000 rpm and the
recovered supernatants were centrifuged for 15 min at 14,000× g.
The lysates were stored at −20˚C. In the first affinity purifica-
tion step, 20–75 mg cell lysates were applied to IgG Sepharose six
Fast Flow beads (Amersham Biosciences; at a ratio of 5µl beads
per 1 mg protein). The resin was prepared according to the man-
ufacturer’s protocol. After overnight incubation at 4˚C, the IgG
resin was washed 10 times with 10 volumes of IPP-150 buffer
(10 mM Tris-HCl pH 8, 150 mM NaCl, 0.1% NP-40) and five
times with 10 volumes of TEV cleavage buffer – TCB (10 mM
Tris-HCl pH 8, 150 mM NaCl, 0.1% NP-40, 0.5 mM EDTA). 20 U
of ActivTEV – Tobacco Etch Virus protease (Invitrogen, Carlsbad,
USA) in TCB (300µl) was then added to the resin and rotated for
2 h at room temperature in order to release the complexes bound
to the resin (100µl). In the second affinity purification step, the
supernatant after TEV cleavage was adjusted with CaCl2 to a 2 mM
final concentration and incubated overnight with 60µl Stratagene
Calmodulin-affinity resin (Agilent Technologies, Cedar Creek,
USA). The resin was then washed three times with 10 volumes of
Calmodulin-binding buffer, CBB (10 mM beta-mercaptoethanol,
10 mM Tris-HCl pH 8, 150 mM NaCl, 0.1% NP-40, 1 mM imida-
zol, 1 mM MgOAc, 2 mM CaCl2) and two times with 10 volumes of
Calmodulin-rinsing buffer, CRB (50 mM ammonium bicarbon-
ate pH 8.0, 75 mM NaCl, 1 mM MgOAc, 1 mM imidazol, 2 mM
CaCl2). For the elution of complexes, the beads were resuspended
and incubated for several minutes with ∼100µl of Calmodulin-
elution buffer, CEB (50 mM ammonium bicarbonate, 15–25 mM
EGTA). Western blotting of input cell lysates and affinity-purified
eluates was performed by standard procedures (Abrahamyan et al.,
2010) using several of the primary antisera described below. TAP
and western blotting results are representative of >5 independent
experiments.
COOMASSIE BLUE STAINING AND GEL SLICE EXCISION
For mass spectrometry analysis, the eluates were fractionated on
4–12% SDS-PAGE and the gels were then subjected to three 5 min
washes in 300 ml double distillated water (ddH2O) and stained
with 100 ml Bio-Safe Coomassie stain (Bio-Rad) for 60 min fol-
lowed by destaining. In total, 23 gel slices from each experi-
ment (St-TAP or St-TAP+HIV-1) were excised, placed in a pre-
washed, low-retention 1.5 ml snap-cap tubes for subsequent in
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gel digestion and liquid chromatography and mass spectrometry
(LC-MS) analysis.
IN GEL DESTAINING AND DIGESTION
Gel bands were diced into ∼1 mm2 pieces and rinsed once with
200µl HPLC-grade water, twice with 200µl 25 mM ammonium
bicarbonate in 50% (v/v) acetonitrile, followed by 100µl ace-
tonitrile to dehydrate the gel plugs, which were then lyophilized.
The dry gel plugs were rehydrated in 5–7µl of 25 mM ammo-
niumbicarbonate, pH 8.0, containing 12.5 ng/µl trypsin. After
rehydration, an additional 30µl of 25 mM ammonium bicarbon-
ate was added and the gel plugs were incubated overnight at 37˚C.
Peptides were extracted from gel plugs by two rounds of incuba-
tion with 50µl of 1% formic acid in 50% acetonitrile. The pooled
extracts were reduced to dryness and reconstituted in mobile phase
A for reversed phase chromatography.
MASS SPECTROMETRY
Digests were analyzed using an Agilent 1100 LC-Ion-Trap-XCT-
Ultra system (Agilent Technologies, Santa Clara, CA, USA) fitted
with an integrated fluidics cartridge for peptide capture, sepa-
ration, and nano-spraying (HPLC Chip). Injected samples were
trapped and desalted on a pre-column channel (40 nl volume; Zor-
bax 300SB-C18) for 5 min with mobile phase A (3% acetonitrile,
0.2% formic acid) delivered by an auxiliary pump at 4µl/min.
The peptides were then reverse-eluted from the trapping column
and separated on the analytical column (150 mm length; Zorbax
300SB-C18) at 0.3µl/min. Peptides were eluted using a 5–70% gra-
dient in mobile phase B (97% acetonitrile, 0.2% formic acid) over
45 min. MS/MS spectra were collected by data-dependent acquisi-
tion, with parent ion scans of 8,100 Th/s over m/z 300–2,000 and
MS/MS scans at the same rate over m/z 100–2,200. Peak-list data
were extracted from these files by DataAnalysis software for the
6300 series ion trap, v3.4 (build 175). Mascot v2.2 (MatrixScience,
Boston, MA, USA) was used to search the MS/MS data using
the following parameters: 1.6 Da precursor ion mass tolerance,
0.8 Da fragment ion mass tolerance, one potential missed cleav-
age, and oxidized methionine as a variable modification. NCBI
nr 2008.01.03 (5,824,077 sequences) was searched, with a restric-
tion to “other viruses” and humans. Mass spectrometry analyses
on isolated TAP eluates were reproduced at least two times in
independent experiments.
ANTIBODIES AND REAGENTS
Mouse anti-Staufen1, anti-UPF (1, 2 and 3), anti-RHA and anti-
AUF1 antibodies were provided by Luc DesGroseillers (Université
de Montréal), Jens-Lykke Andersen (University of California),
Juan Ortin (Centro Nacional de Biotecnologia, Madrid, Spain)
and William Rigby (Dartmouth University, NH, USA), respec-
tively (Villace et al., 2004; Ajamian et al., 2008; Abrahamyan et al.,
2010). Rabbit anti-IMP1 and anti-ABCE1 antibodies were gener-
ous gifts from Finn Nielsen (University of Copenhagen) and from
Jaisri Lingappa (University of Washington; Zimmerman et al.,
2002; Milev et al., 2010), respectively. Mouse anti-Tsg101 and anti-
L7 antibodies were purchased from Novus Biologicals (Littleton,
USA), anti-eF1α, anti-TDP-43 and anti-CRM1 were purchased
from Upstate (Millipore), ProteinTech Group (Chicago, USA) and
Santa Cruz (California, USA), respectively; rabbit anti-p17 and
sheep anti-gp120 were obtained from the NIH (Abrahamyan et al.,
2010). For all immunofluorescence (IF) experiments, secondary
AlexaFluor anti-mouse, anti-rabbit or anti-sheep conjugated anti-
bodies were used (Invitrogen) as previously described (Milev et al.,
2010).
IMMUNOFLUORESCENCE, FISH AND CONFOCAL MICROSCOPY
At 24–48 h after transfection, cells were washed two times with
1× PBS and fixed in 4% PFA for 20 min, washed two times
with 1× PBS and treated with 0.2% Triton X-100 for 10 min.
IF and FISH were performed essentially as previously described
(Lehmann et al., 2009; Milev et al., 2010; Vyboh et al., 2012). Cells
were then incubated for 10 min with 0.1 M glycine, washed and
blocked for 30 min in 1× BSA (Roche Applied Science, Germany).
The primary antibody was incubated for 1.5 h at room tempera-
ture. Cells were washed 2× with PBS and subsequently incubated
with secondary antibody for 30 min. After this step the glass cover-
slips were washed 2× with PBS, mounted on slides and visualized
with a Carl Zeiss Pascal LSM5 laser scanning confocal microscope
(Carl Zeiss, Germany).
EXPRESSION VECTORS
Plasmids pcDNASt-TAP and pcDNA-TAP were constructed as
previously described (Villace et al., 2004). Proviral DNA, pNL4-3
was described in previous work (Adachi et al., 1986; Chatel-Chaix
et al., 2004). pNL4-XX, a proviral DNA derived from pNL4-3,
harbors two mutations in the gag open reading frame to prevent
Gag and Gag/Pol synthesis, was described elsewhere (Poon et al.,
2002; Abrahamyan et al., 2010). Constructs expressing Staufen1-
HA, pGL3-IMP1-VenusC and pGL3-MS2-Venus (full length) were
described previously (Milev et al., 2010). pCMV-Gag-RRE was
described earlier (Lingappa et al., 2006).
SUBCELLULAR FRACTIONATION
Following transfection, cells were washed with ice cold PBS,
homogenized in an equal volume of XB Buffer (20 mM HEPES pH
7.9, 1.5 mM MgCl2, 0.5 mM DTT, protease inhibitor cocktail). The
homogenate was centrifuged for 10 min at 5,000 rpm to remove
the insoluble material. The supernatant (1 mg total protein) was
applied on the top of a 5 ml 5–50% pre-loaded sucrose gradient in
XB buffer, as described (Yoon and Mowry, 2004). Lysates were sep-
arated by centrifugation at 44,000 rpm for 2 h in SW55i beckman
rotor at 17˚C. 18–20 250µl fractions were collected and resolved
by SDS-PAGE or processed for slot blot analyses.
RNA SLOT BLOT ANALYSES
In order to evaluate vRNA fractionation in sucrose gradient frac-
tions, an aliquot of each eluate was mixed 1:3 with GTC and FFM
solution (10× OPS buffer, 37% Formaldehyde, 99% Formamide)
and heated at 65˚C for 15 min and transferred to 0.45µm nylon
membrane by intermittent suction for slot blot analyses using a
Gibco/BRL slot blot apparatus. A [32]P-labeled cDNA probe to the
HIV-1 5′ gag coding region to recognize the vRNA only was pre-
pared using random prime labeling kit, as described (Yao et al.,
1998; Mouland et al., 2000).
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RESULTS
GENERATION OF STAUFEN1-TAP AND CONTROL TAP STABLE CELL
LINES
Tandem affinity purification is a powerful method for the spe-
cific isolation of protein complexes under native conditions. In
order to characterize Staufen1 HIV-1 RNP complexes and to deter-
mine Staufen1-binding partners, we generated neomycin-resistant
human 293T and Jurkat T cell lines expressing Staufen1-TAP (or
St-TAP) and TAP control cell lines (Figures 1A–D; Puig et al.,
2001). Cells were transfected with pcDNA3 in which a TAP tag
was cloned at the carboxy-terminus of the Staufen155 kDa cDNA
(Villace et al., 2004; Ajamian et al., 2008). Previous studies have
demonstrated that St-TAP protein has the same properties as
the native protein (Villace et al., 2004). Two of the 12 single-
cell clones that were expanded in expressed the fusion protein
as assessed by western blotting. St-TAP#11 was used for all sub-
sequent experiments (Figure 1B; shown in Ajamian et al., 2008),
because the expression levels were similar to that of endogenous
Staufen155 kDa. Jurkat St-TAP#13 (Figure 1C) was used for sub-
sequent purification and characterization of Staufen1 complexes.
A control cell line was also generated expressing only the TAP
tag (Figure 1D). The subcellular distribution of TAP and St-TAP
proteins in these stable 293T cell lines were assessed by IF using a
monoclonal anti-Protein A antibody that recognizes the IgG bind-
ing domain of Protein A (the carboxy-terminal part of the TAP
tag). TAP tag was found to be uniformly distributed throughout
the cell (Figure 1E, left panel) and St-TAP was found principally
in the cytoplasm of stable expressing cells (Figure 1E, right panel),
corresponding to the localization pattern of endogenous Staufen1
(Wickham et al., 1999; Thomas et al., 2005). These results indicate
FIGURE 1 | Generation and isolation of stable neomycin-resistant cell
lines expressing Staufen1-TAP andTAP proteins. (A) Structures of the
Tandem Affinity Purification (TAP) tag cassette and Staufen1-TAP fusion
protein. TAP tag consists of two sequences responsible for the affinity
purification – IgG binding domain of Protein A and Calmodulin-binding
peptide separated by a unique cleavage site for Tobacco Etch Virus (TEV)
protease. (B,C) Expression levels of St-TAP in stable 293T and Jurkat T cell
clones detected by western blotting analysis using a monoclonal mouse
anti-Staufen1 antibody that recognizes both Staufen155 (55 kDa), Staufen163
(63 kDa), the endogenous isoforms and exogenous St-TAP (∼75 kDa) fusion
protein, respectively. GAPDH is the loading control. 293T cell clone #11 and
Jurkat T cell clone #13 were used in experiments. (D) Expression levels of
TAP protein in 7 (#1–#7) control 293T clones and verified by western
blotting. Clone #6 was used in control experiments. (E) Stable cell lines
TAP#6 and St-TAP#11 were stained with mouse monoclonal anti-protein A
antibody. The primary antibody was detected by Alexa Fluor 488 goat
anti–mouse IgG antibody and the stained cells were visualized by
epifluorescence microscopy.
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that the Staufen1 component of the fusion protein, rather than the
TAP tag, is responsible for correctly localizing the fusion protein
to the cytosol.
PURIFICATION OF STAUFEN1 HIV-1 RIBONUCLEOPROTEIN COMPLEXES
We used the TAP-to-MS protocol to discover compositional
changes in Staufen1-containing complexes when HIV-1 is
expressed. We performed parallel purifications of extracts
obtained from stably expressing St-TAP (Mock) or TAP (con-
trol) cell lines transiently transfected with pNL4-3. At 40 h post-
transfection cells were harvested and 20 mg total protein was used
for TAP purification. We also isolated Staufen1 complexes from
both HIV-1 infected or uninfected Jurkat T cells that expressed
St-TAP. Staufen155 kDa and St-TAP were present in RNPs both
before and after affinity purification (Figures 2A,C). The TEV
protease-mediated cleavage of St-TAP (75 kDa) fusion proteins
resulted in the formation of St-CBP protein that migrated at
∼64 kDa (Figures 2A,C). Both endogenous 55 and 63 kDa iso-
forms of Staufen1 were recruited to RNPs likely due to their
ability to form homo- and heterodimers and to accumulate in
RNPs (Martel et al., 2010). When HIV-1 was expressed, higher
amounts of endogenous Staufen1 were found in the eluates.
FIGURE 2 | Characterization of the tandem affinity-isolated Staufen155 kDa
RNPs by western blot and mass spectrometry analysis. (A) Separation of
proteins from cell lysates (Inputs) before (left panels) and after (right panels)
tandem affinity purification (Staufen1 complexes) 0.25 mg of total protein
obtained from extracts of TAP (control) or Staufen1-TAP expressing cell lines
in the absence or presence of HIV-1 were used for affinity purification.
Initially, the membrane was blotted with mouse anti-Staufen1 monoclonal
antibody shown on the top left and right panels. The star (*) indicates the
position of the purified St-CBP protein. (B) The proteins from the eluted
Staufen155 kDa complexes and those from TAP alone (control) were purified
from 75 mg of total protein, separated on SDS-PAGE and subsequently
stained with Bio-Safe Coomassie Blue. Four bands were excised from gel
lanes (II) and (III) for the identification of potential contaminating proteins. 23
bands from St-TAP and St-TAP HIV-1 (lanes IV and V) were excised and
analyzed with mass spectrometry. Lane I represents the molecular weights
in kDa of the protein standards. (C) Dual affinity purification of Staufen1
complexes derived from Jurkat T St-TAP stable cell lines in the absence or in
the presence of HIV-1.
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Furthermore, the precursor Gag protein was found in association
with Staufen1 but not any of its smaller, mature cleavage prod-
ucts [CA (p24), MA (p17), NC (p7), or p6 (Figures 2A,C)]. This
result is in accordance with our previous data showing the selec-
tive manner in which Staufen1 and Gag interact (Chatel-Chaix
et al., 2004). Interestingly, in the majority of the experiments we
also detected pr160Gag/Pol (Gag/Pol), probably as a result of its
interaction with Staufen1, Gag and the presence of vRNA that
facilitates such associations during HIV-1 assembly (Khorchid
et al., 2002). The affinity purification was validated by western
blotting using antibodies against several proteins that were previ-
ously found to associate with Staufen1 such as RHA, ribosomal
protein L7a (Villace et al., 2004) and poly-A binding protein
(PABP; Figure 2A; Miroslav P. Milev and Andrew J. Mouland, data
not shown). Western blotting analysis revealed that eukaryotic
translation elongation factor-1α (eF1α) is a Staufen1-interacting
partner. This is the first time that the association with eF1α with
Staufen1 has been reported; it nevertheless interacts with Gag
and is incorporated in HIV-1 particles (Cimarelli and Luban,
1999).
Previously, Staufen1 was found to interact with the nucleo-
cytoplasmic shuttling protein, Barentsz (Macchi et al., 2003), a
component of exon junction complexes and an important player in
nonsense-mediated mRNA decay (NMD) – a surveillance process
that degrades aberrant mRNAs containing premature termination
codons (Palacios et al., 2004). Staufen1-mediated mRNA decay
was also described to involve Staufen1 and the major NMD factor,
Upf1 (Kim et al., 2005). Moreover, these two proteins are found
in association with APOBEC3G RNPs that might be involved in
retroviral restriction (Kozak et al., 2006). These findings provide
molecular and biochemical links between mRNA splicing, traf-
ficking and decay. Therefore we wanted to determine the potential
association of some of the main NMD factors such as Upf1, Upf2,
and Upf3 in Staufen1-containing RNPs in the absence or presence
of HIV-1 infection. Our results clearly demonstrate the association
of Upf1 with the Staufen1 HIV-1 RNP complexes. When HIV-1
was expressed, we consistently observed approximately threefold
more Upf1 eluting from the Staufen1 column compared to that
found when HIV-1 was not expressed (Figures 2A,C). Upf2 was
not detected in any of the experiments using 293T or Jurkat T
Staufen1-TAP cell lines (Figures 2A,C) indicating that Upf2 is
absent or is not stably bound in the Staufen1 RNP (Ajamian et al.,
2008). The absence of Upf2 was expected since Staufen1 and Upf2
compete for binding with Upf1. Upf3b was also detected in St-TAP
complexes derived from 293T cells as assessed by western blotting
(Figure 2A).
We have demonstrated an important role for Staufen1 in the
process of Gag multimerization, trafficking and viral assembly that
could be coordinated with a role in the encapsidation of vRNA
(Chatel-Chaix et al., 2007; Abrahamyan et al., 2010; Milev et al.,
2010). We wished to verify whether the function of Staufen1 in Gag
multimerization, assembly and vRNA encapsidation are linked to
the function of other cellular Gag-interacting factors. To this end,
we chose the host ATP-binding cassette protein ABCE1 which asso-
ciates with Gag shortly after its synthesis (Dooher et al., 2007)
and is critical for the proper generation of an immature HIV-1
capsid (Zimmerman et al., 2002). As in seen with Staufen1, the
NC domain of Gag is a necessary and sufficient determinant for
binding ABCE1 (Zimmerman et al., 2002; Lingappa et al., 2006).
Equal amounts of ABCE1 were detected in Staufen1 RNPs iso-
lated from cells with or without HIV-1 expression (Figure 2A,
bottom panel). Several studies have demonstrated that tumor sus-
ceptibility gene 101 (TSG101) protein binds the N-terminal p6
region of Gag and is responsible for the release of the virus from
the plasma membrane (Sun et al., 1999; Babst et al., 2000; Gar-
rus et al., 2001; VerPlank et al., 2001). We did not find TSG101 in
the Staufen1 eluates in any of the cell lines nor could we detect
it by mass spectrometry. In fact, other candidate endosomal sort-
ing complex required for transport (ESCRT) proteins were not
detected in these Staufen1 RNPs (Miroslav P. Milev and Andrew
J. Mouland, data not shown). Thus, despite its interaction with
the viral protein Gag, TSG101 appears to be excluded from these
particular Staufen1 RNPs suggesting separable functions during
HIV-1 replication. Likewise, we did not detect either Vif or Vpr
by mass spectrometry and/or western blotting analyses, both well-
described interacting partners of Gag (Lavallee et al., 1994; Kondo
et al., 1995; Bouyac et al., 1997; Syed and McCrae, 2009). We pro-
pose that this negative result could be due to their low abundance
in Staufen1 HIV-1 complexes or that these viral proteins interact
with distinct subpopulations of Gag that exclude Staufen1 (Klein
et al., 2007).
IDENTIFICATION OF PROTEINS ASSOCIATED WITH STAUFEN1 HIV-1
RNPs
After validating our RNP purification protocol by western blotting,
we proceeded to mass spectrometry analysis to identify proteins
that associate with Staufen1 in these particles both in the absence
or presence of HIV-1. For these experiments, stably expressing TAP
cells were mock transfected or transfected with a proviral plasmid
expressing HIV-1 (pNL4-3), lysed and then used for affinity purifi-
cation. In the eluates from the control TAP samples [Figure 2B,
lines (II ) and (III )] we detected a few discrete bands. We sectioned
the TAP gel lanes into four pieces (shown with numbers) and ana-
lyzed them by mass spectrometry. The proteins that were detected
included keratins, immunoglobulins, interferon alpha inducible
protein (IFI6), tubulin beta-2 and heat shock protein 90 and since
they were found in the control TAP samples, they were considered
to be contaminants.
Stable St-TAP cell lines were then mock transfected or trans-
fected with pNL4-3. Lysates were harvested and following SDS-
PAGE and Coomassie Blue staining, we observed a similarity in
banding pattern between Staufen1-TAP and Staufen1-TAP HIV-1
RNPs [Figure 2B, lines (IV ) and (V )]. In a typical experiment, we
excised at least 23 bands from the St-TAP lane and correspond-
ing bands from St-TAP HIV-1 lane. Each band was subjected to
LC-MS/MS analysis and the data was concatenated and searched
against either the NCBI nr human or virus databases as described
in Materials and Methods. A separate randomized decoy database
search was performed and the search results were filtered to achieve
a False Discovery Rate (FDR) of less than 1%. This corresponded
to a score cutoff of 48 and 47 for the human and viral databases,
respectively.
We typically detected about 200 proteins in both Staufen1-TAP
control and Staufen1-TAP HIV-1 RNPs (Figure 3; Tables S1 and
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FIGURE 3 | Staufen1 RNPs contain proteins involved in the localization,
stabilization and trafficking of mRNAs and HIV-1 vRNA. Graphical
representation and comparison of Staufen1-associated proteins isolated
from 293T cells in the absence (top panel) and the presence of HIV-1
(middle panel). The newly identified proteins were grouped on the basis of
their main function or the process in which they are involved in both control
and HIV-1 conditions. The subcellular distribution of proteins found in
Staufen1-TAP (blue bars) and Staufen1-TAP HIV-1 (orange bars) RNPs is
depicted (bottom panel). The information for each protein was obtained from
the UniProt database.
S2 in Supplementary Material). As expected, some of the pro-
teins identified had been previously shown to interact and/or
associate with Staufen1, such as hnRNP U, RHA, NFAR, nucle-
olin, α-tubulin and numerous ribosome subunits (Brendel et al.,
2004; Villace et al., 2004). The regulator of nonsense transcripts,
Upf1, was also identified (Kim et al., 2005). The majority of the
proteins were detected with two or more unique peptides; single
peptide hits are also reported in the appended Tables S1 and S2 in
Supplementary Material.
We divided all identified proteins from both cohorts into sev-
eral main categories in respect to their known functions. As shown
in the Figure 3, we generated 10 functional categories, includ-
ing viral proteins in the case when HIV-1 was expressed. The
largest group encompassed mRNA-binding proteins that partici-
pate in different aspects of mRNA metabolism in the cell (RNA
transcription, splicing, stability, transport and degradation) and
represent ∼29% of the total number of proteins in the Staufen1
RNPs and ∼35% of the total number of proteins in Staufen1-
HIV-1 RNPs. These proteins included numerous heterogeneous
nuclear ribonucleoproteins (RNP), DEAD-box family helicases
and NMD factors Upf1 and Upf3b [detected by western blot in
both types RNPs (Figure 2A) and by mass spectrometry – only
in Staufen1 HIV-1 RNPs (Table 1)]. Splicing and mRNA trans-
port factors, such as SFPQ, SF3B2 and endogenous Staufen1 and
nucleocytoplasmic shuttling proteins, such as nucleolin, nuclear
factor associated with dsRNA,NFAR-1 90 kDa isoform andYB-1 (a
universal component of cytoplasmic mRNPs) were also included
with this group. Several new mRNA-binding components associ-
ated within Staufen1 in both control and HIV-1 conditions. These
included leucine-rich protein 130 kDa, LRP130, an RNA-binding
protein that accumulates with mRNPs at the nuclear envelope and
endoplasmic reticulum (Tsuchiya et al., 2004). Three members
of the highly conserved VICKZ family of RNA-binding proteins
(Vg1 RBP/Vera, IMP1,2,3, CRD-BP, KOC, ZBP-1) and insulin-
like growth factor II mRNA-binding protein 1, 2 and 3 (IMP1 and
IMP2 in the native complexes and IMP1 and IMP3 in those puri-
fied from HIV-1-expressing cells) were also detected [Reviewed
in (Yisraeli, 2005)]. The RNA/DNA-binding protein TDP-43 was
detected by mass spectrometry only in HIV-1-containing com-
plexes, but was later confirmed by western blotting analysis in
both the presence and absence of HIV-1. Structurally analogous
to the hnRNPs, this protein was originally described as a factor
that modulates HIV-1 gene expression at the transcriptional level
(Ou et al., 1995).
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Table 1 | Unique proteins identified by mass spectrometry in Staufen1-HIV-1 RNPs.
Protein name* UniProt accession
number**
Role in HIV-1
replication?
Reference
26S protease regulatory subunit S10B (PSMC6) P62333 Unknown N/A
26S proteasome non-ATPase regulatory subunit 2 Q13200 Unknown N/A
60S ribosomal protein L29 (RPL29) P47914 Unknown N/A
7-dehydrocholesterol reductase (DHCR7) Q9UBM7 Yes (van’t Wout et al., 2005)
Actin-related protein 2/3 complex subunit 4 P59998 Yes (Komano et al., 2004; Chertova et al., 2006)
ADP-ribosylation factor 4 (ARF4/ARF2) P18085 Unknown N/A
ADP-ribosylation factor 6 (ARF6) P62330 Yes (Ono et al., 2004)
Alpha-internexin (INA) Q16352 Unknown N/A
AP-2 complex subunit mu (AP-2M1) Q96CW1 Yes (Le Gall, 1998; Craig et al., 2000; Batonick
et al., 2005)
AP-3 complex subunit delta-1 (AP-3D1) O14617 Yes (Dong et al., 2005)
CDP-diacylglycerol–inositol 3-phosphatidyltransferase (CDIPT) O14735 Unknown N/A
Cleavage and polyadenylation specificity factor subunit 1 (CPSF1) Q10570 Unknown N/A
Cleavage and polyadenylation specificity factor subunit 7 (CPSF7) Q8N684 Unknown N/A
Coatomer subunit zeta-1 (COPZ1) P61923 Unknown N/A
Copine-3 O75131 Unknown (Chertova et al., 2006)
Delta-1-pyrroline-5-carboxylate synthetase (ALDH18A1) P54886 Unknown N/A
Double-stranded RNA-specific adenosine deaminase (ADAR) P55265 Yes (Phuphuakrat et al., 2008; Doria et al., 2009)
Dynamin-2 (DNM2) P50570 Yes (Pizzato et al., 2007)
E3 ubiquitin-protein ligase (BRE1A) Q5VTR2 Unknown N/A
Env P03377 Yes (Freed, 2001)
Eukaryotic initiation factor 4A-III (eIF4A3) P38919 Unknown N/A
Eukaryotic translation initiation factor 3 subunit E (eIF3E) P60228 Unknown N/A
Gag P12493 Yes (Freed, 1998)
Gag/Pol P12493 Yes (Jacks et al., 1988)
GTP-binding nuclear protein Ran P62826 Yes (Askjaer et al., 1998)
Heat shock 70 kDa protein 1L P34931 Yes (Rasheed et al., 2008)
Heterogeneous nuclear ribonucleoprotein A/B Q99729 Yes (Mouland et al., 2001)
Heterogeneous nuclear ribonucleoprotein F (hnRNP F) P52597 Unknown N/A
Heterogeneous nuclear ribonucleoprotein H2 P55795 Unknown N/A
Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) P31942 Unknown N/A
Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) O60506 Yes (Hadian et al., 2009)
Heterogeneous nuclear ribonucleoprotein R (hnRNP R) O43390 Yes (Hadian et al., 2009)
HIV-1 Rev-binding protein 2 Q13601 Unknown N/A
Importin-7 O95373 Yes (Fassati et al., 2003; Zaitseva et al., 2009)
Insulin-like growth factor II mRNA-binding protein-3 O00425 Unknown N/A
IQ motif containing GTPase activating protein 1 P46940 Unknown (Chertova et al., 2006)
Leucine-rich repeat-containing protein 59 (LRRC59) Q96AG4 Unknown N/A
Long-chain-fatty-acid–CoA ligase 3 (ACSL3) O95573 Unknown N/A
Mannosyl-oligosaccharide glucosidase (MOGS) Q13724 Unknown N/A
Nef P05855 Yes (Arhel and Kirchhoff, 2009)
NF-kappaB repressing factor (NRF) A3F768 Yes (Dreikhausen et al., 2005)
Non-POU domain-containing octamer-binding protein (NONO) Q15233 Yes (Zolotukhin et al., 2003)
Nuclear pore complex protein 155 (Nup155) O75694 Yes (Brass et al., 2008; Lee et al., 2010)
Peroxiredoxin-6 P30041 Unknown (Chertova et al., 2006)
Phosphatidylserine synthase 1 (PTDSS1) P48651 Unknown N/A
Pre-mRNA 3′-end-processing factor FIP1 (FIP1L1) Q6UN15 Unknown N/A
(Continued)
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Table 1 | Continued
Protein name* UniProt accession
number**
Role in HIV-1
replication?
Reference
Probable ATP-dependent RNA helicase (DDX17) Q92841 Unknown N/A***
Probable ATP-dependent RNA helicase (DDX27) Q96GQ7 Unknown N/A
Programmed cell death 8 (AIFM1) O95831 Unknown N/A
Protein transport protein Sec61 subunit alpha isoform 1 (SEC61A1) P61619 Unknown N/A
Protein tyrosine phosphatase-like protein (PTPLAD1) Q9P035 Unknown N/A
Putative RNA-binding protein Luc7-like 2 Q9Y383 Unknown N/A
Pyruvate dehydrogenase E1 component subunit beta (PDHB) P11177 Unknown (Ringrose et al., 2008)
Ras-related GTP-binding protein A (RRAGA) Q7L523 Unknown N/A
Ras-related protein Rab-10 P61026 Unknown (Chertova et al., 2006)
Ras-related protein Rab-5C P51148 Yes (Vidricaire and Tremblay, 2005; Chertova
et al., 2006)
Ras-related protein Rab-8A P61006 Unknown (Chertova et al., 2006)
Ribonucleoprotein PTB-binding 1 Q8IY67 Unknown N/A
Signal recognition particle receptor subunit beta (SRPRB) Q9Y5M8 Unknown N/A
Spliceosome RNA helicase (BAT1) Q13838 Unknown (Limou et al., 2009)
Splicing factor, arginine/serine-rich 13A (SFRS13A) O75494 Unknown N/A
Splicing factor, arginine/serine-rich 4 (SFRS4) Q08170 Unknown N/A
Splicing factor, proline- and glutamine-rich (SFPQ) P23246 Yes (Zolotukhin et al., 2003)
T-complex protein 1 subunit beta P78371 Unknown N/A
THO complex 4 (THOC4) Q86V81 Unknown N/A
THO complex subunit 2 (THOC2) Q8NI27 Unknown N/A
T-plastin polypeptide (plastin-3) P13797 Unknown N/A
Tubulin alpha-4A chain P68366 Unknown (Chertova et al., 2006)
V-type proton ATPase subunit d 1 P61421 Unknown (Chertova et al., 2006)
Zinc finger RNA-binding protein (ZFR) Q96KR1 Unknown N/A
*Viral proteins are highlighted; **Universal Protein Resource -– UniProt database [http://www.uniprot.org/]; *** Not applicable.
The second most predominant category relates to proteins
involved in RNA translation (∼23 and ∼18% in the absence and
presence of HIV-1, respectively) and includes ribosomal, transla-
tion initiation and elongation factors and several aminoacyl-tRNA
synthetases. Proteins such as PABP1, eukaryotic translation initi-
ation, and elongation factors – eIF3 (α, β and ε), eIF4A (two iso-
forms – 1 and 3) and eF1 (α, γ and δ isoforms) were also detected.
Proteins involved in cell metabolism represented ∼8% of the
total number of proteins in Staufen1-containing RNPs isolated
in the absence of HIV-1 and ∼9% in the presence of HIV-1.
These included enzymes that regulate different aspects of the gen-
eral cellular metabolism of carbohydrates, lipids, amino acids,
and nucleotides, such as pyruvate kinase and pyruvate dehy-
drogenase, lactate dehydrogenase and glyceraldehyde-3-phosphate
dehydrogenase, fatty acid synthase, ATP-citrate synthase and
others (Figure 3; Tables S1 and S2 in Supplementary Material).
Diverse proteins involved in cytoskeleton formation and struc-
ture (∼4 and ∼5% in the absence HIV-1 and presence of HIV-1,
respectively), including actin, tubulin,vimentin,as well as IQGAP1
were detected (Figure 3; Tables S1 and S2 in Supplementary Mate-
rial). We also placed Matrin 3 in this category as it is a novel
Staufen1-binding partner that was originally reported to be one
of the major structural proteins of the inner nuclear matrix
(Belgrader et al., 1991). An interesting feature of this protein is
its ability to retain A–I edited dsRNAs in the nucleus (Reviewed in
DeCerbo and Carmichael, 2005). Moreover, it has been shown in
association with APOBEC3G RNPs (Kozak et al., 2006) and with
3′-untranslated region (UTR) of the hepatitis C genome (Harris
et al., 2006).
Approximately 8% (−HIV-1) and 10% (+HIV-1) of Staufen1-
binding partners were vesicular and protein transport proteins.
As mentioned earlier, TSG101, a member of ESCRT-I was not
detected by western blotting or by mass spectrometry. Instead, we
identified some other proteins involved in the control of endoso-
mal dynamics and in intra-Golgi vesicular transport, including
vesicle budding from Golgi membranes. These included Ras-
related proteins (Rab-5C, Rab8, Rab-10), some of the coatomer
protein complex subunits – COP (α, γ and ζ), adaptor proteins –
(AP-2, AP-3) and ADP-ribosylation factors (1, 4, 5 and 6). In
addition, some cellular factors regulating the processes of protein
folding (heat shock proteins, T-complex proteins, Calnexin), ubiq-
uitination and N-linked glycosylation (Ribophorin-1) constitute
the protein processing group [∼8% (−HIV) and∼9% (+HIV-1)].
Finally, the remaining identified proteins included those
involved in ion transport (including sodium/potassium-
transporting ATPase, several ATP synthases) and apoptosis/cell
cycle/DNA replication/signaling (CDC5L, MCM7 and RACK1),
while the remaining proteins were grouped under “others” and
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included mitochondrial and nucleocytoplasmic transport pro-
teins (Nup155, Importin1, Importin-7, Xpo1, Xpo2 and ADP/ATP
translocase; Figure 3 and see Tables S1 and S2 in Supplementary
Material).
We detected 45 proteins from Staufen1 HIV-1 RNPs (including
viral proteins such as Gag, Gag/Pol, Env and Nef; Tables S1 and
S2 in Supplementary Material) that are virion-associated (Ott,
2002, 2008; Cantin et al., 2005; Komano et al., 2005; Chertova
et al., 2006; Goff, 2007) representing 22% of the total number of
proteins found in the Staufen1 HIV-1 complexes. Among them
were RHA, IQGAP1, actin, vimentin, eF1α, Staufen1, IMP1 and
heat shock proteins Hsp60, Hsp70 and Hsc70. The latter three are
incorporated within the membrane of the viruses and are impor-
tant for virus infectivity (Gurer et al., 2002). Upf1, which is found
in the HIV-1 RNP, also represents a virion-incorporated protein
(Abrahamyan et al., 2010).
CHARACTERIZATION OF INTERACTIONS BETWEEN STAUFEN1 AND
SEVERAL NOVEL PARTNERS USING BIOCHEMICAL AND
IMMUNOFLUORESCENCE METHODS
We confirmed the association of several proteins with Staufen1
complexes using IP and IF analyses. For the purpose of these exper-
iments, we chose three predominantly nuclear proteins: AU-rich
element RNA binding protein 1, AUF1, TAR DNA-binding pro-
tein, TDP-43 and chromosomal regional maintenance protein 1
(CRM1 or Xpo1), a factor that mediates the nuclear export and
ABCE1 (also known an HP68). IP experiments were performed
with lysates derived from HeLa cells. To determine the RNA
dependence of these interactions, equal amounts of lysates were
treated with or without RnaseA for 30 min on ice before IP. Our
results demonstrate the RNA-independent character of Staufen1
interactions with CRM1 and ABCE1 (Figures 4A,B, IP panels),
whereas those between both Staufen1 and TDP-43 and Staufen1
and AUF1 appeared to be RNA-dependent (Figures 4C,D, IP
panels). We detected IMP1 in three independent MS analyses
and further confirmed its presence in affinity-isolated complexes
using polyclonal rabbit anti-IMP1 antibody (Figure 2A, bottom
panel). IMP1 is a human ortholog of chicken Zipcode binding
protein 1 (ZBP-1) and belongs to VICKZ protein family (Yisraeli,
2005). Different studies indicate similar functions for IMP1 and
Staufen1 with respect to mRNA transport, translational control
and localization. IMP1 binds fragile×mental retardation pro-
tein (Rackham and Brown, 2004) and PABP1 (Patel and Bag,
2006) and associates with APOBEC3G (Kozak et al., 2006), YB-
1, nucleolin and hnRNP A1 (Jonson et al., 2007), proteins that
also associate with Staufen1. Recently, IMP1 has been found to
bind to HIV-1 Gag (Roy et al., 2006) and in our own work
this protein also associates with lipid raft domains (Milev et al.,
2010). We performed IP experiments for IMP1 (Figure 4E, IP
panel) and observed that its association with Staufen1 was also
RNA-independent.
To further demonstrate the interrelationships between Staufen1
and these proteins, we performed laser scanning confocal
microscopy to examine their distribution in cells. We trans-
fected HeLa cells with plasmids expressing Staufen1-HA and
24 h later, we fixed and stained the cells with antibodies recog-
nizing the HA-epitope and the endogenous proteins that were
used in the IPs, with the exception that we used an anti-GFP
to detect IMP1-VenusC (IMP1-VC). We observed co-localization
of Staufen1 with ABCE1 and partial co-localization with TDP-
43, AUF1 (Lund et al., 2012) and CRM1 [Figures 4A–D, co-
localization with Staufen1 panels; Manders’ coefficients (%) are
shown]. As expected, Staufen1 and IMP1 co-localized in cyto-
plasmic particles, but this was only true for a proportion of
these proteins (Figure 4E, co-localization with Staufen1 panel).
Finally, the possible interactions of these novel Staufen1 part-
ners with vRNA and Gag were elucidated by combined FISH
and IF co-analyses in HIV-1-expressing cells. We transfected HeLa
cells with both pNL4-3 proviral DNA plasmids coding for IMP1-
VenusC (Figures 4A–E, distribution+HIV-1 panels). Cells were
fixed and stained with rabbit anti-CRM1, anti-ABCE1 anti-TDP-
43, anti-AUF1, or anti-GFP (to detect IMP1-VenusC; all in red,
Figures 4A–E, distribution+HIV-1 panels), along with sheep anti-
p17 to detect Gag (shown in blue) and FISH was performed to
detect viral RNA (shown in green). The presence of HIV-1 caused
the partial accumulation of AUF1 in the cytoplasm. The mecha-
nism, however, that underlines this phenomenon is unclear but
could be due to the HIV-1 imposed block on nuclear import
(Monette et al., 2009) and the functional significance of this inter-
action was recently demonstrated (Lund et al., 2012). Importantly,
ABCE1, currently implicated in the generation of HIV-1 capsids,
co-localized with the vRNA. At present, we do not know if this
is via a direct or indirect interaction. The co-localization of IMP1
with viral components was estimated in cells simultaneously trans-
fected with IMP1-VenusC and pNL4-3 plasmids. We noticed that
cells overexpressing IMP1-VenusC (Figure 4E, shown with white
arrows) had an apparent decrease in the signal for vRNA. Cells
that did not express or expressed IMP1-VenusC at lower levels
showed higher accumulations of vRNA (Figure 4E, white arrow
head). This negative effect on vRNA in HIV-1 positive cells was
observed in more than 55% of the cells.
SUCROSE DENSITY GRADIENT ANALYSIS OF STAUFEN1 HIV-1 RNPs
Sucrose density gradient analyses were then performed to further
characterize Staufen1 RNP dynamics when HIV-1 was expressed.
The biochemical examination of these RNPs is important since
Staufen1 is found in several RNPs relevant to HIV-1 (Chiu et al.,
2006; Abrahamyan et al., 2010) but it also selectively associates
with the vRNA in complex with Gag and other host proteins
(Chatel-Chaix et al., 2004, 2008; Ajamian et al., 2008). More-
over, in our earlier study, we demonstrated that Staufen1 RNPs
were plastic in size but co-associated with Gag and vRNA signals
(Abrahamyan et al., 2010). We therefore assessed the distribution
of Staufen1 RNPs by sucrose density centrifugation to determine
how HIV-1 influences this. HA-Staufen1 was transfected into HeLa
cells without or with pNL4-3 proviral HIV-1 DNA. Lysates were
processed for sucrose density gradient analyses. Fractions were
collected from the top of the gradient and HIV-1 vRNA was quan-
titated by slot blot analysis. An aliquot of each gradient fraction
was run on SDS-PAGE and western blotting was performed to
identify Staufen1-HA and several of the newly identified members
of Staufen1-TAP-containing host proteins (e.g., RP-L7a, TDP-43
and ABCE1, Table S2 in Supplementary Material) and Gag in HIV-
1 samples (Figures 5A,B). In some cases, lysates were treated with
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FIGURE 4 | Confirmation of the in vivo association of Staufen1 with
several of the host factors that were identified in Staufen1-contain RNP
complexes. (A–E) CRM1, ABCE1, TDP-43, AUF1 and IMP1 (as IMP1-VenusC)
were immunoprecipitated from 500 mg total protein lysate of HeLa cells. For
the immunoprecipitation of IMP1 HeLa cells were transfected with
IMP1-VenC or Venus-full length (as a control) and immunoprecipitated with a
mouse anti-GFP antibody. The images to the immediate right of the IPs show
the patterns of co-localization of CRM1, cytoplasmic RNAse L inhibitor
(ABCE1), AUF1, TAR DNA-binding protein (TDP-43) and IMP1 with
Staufen1-HA. The Manders’ coefficients (average from >10 cells per
experiment derived from Staufen-HA expressing cells only, in %) are shown
to provide an estimate of the co-localization. At the far right, the distribution of
each host protein (in red) is shown in relation to Gag (blue) and the viral
genomic RNA (vRNA, green) in HIV-1-expressing cells as determined by laser
scanning confocal microscopy. Cells overexpressing IMP1-VenusC are
indicated with white arrows in (E). Size bars are 10µm.
RNAse A to determine RNA-dependency. These analyses revealed
that there was no consistent shift in the sedimentation profile of
Staufen1-HA complexes in mock and HIV-1-expressing cells and
they mainly fractionated in denser fractions #11–18 (Figure 5A).
This was also true for those for the selected Staufen1-associated
host proteins. However, Gag sedimented in two regions of the
density gradient, in both a light (fractions #1–7) and a more dense
region (fractions #12–20; Figure 5B), while the vRNA only sed-
imented in very dense fractions (#16–20) in this assay. RNAse A
treatment eliminated the vRNA,but also disrupted the distribution
of viral and host proteins in the dense fractions leading to their
migration in lighter density fractions, with the exception of the
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FIGURE 5 | Staufen1 co-fractionates with Gag and vRNA in gradient
density fractionation analyses. (A) HeLa cells were either mock
transfected with empty vector, pcDNA3, or with a plasmid that
expresses Staufen1-HA. The transfected cells were collected 24 h later,
lysed and were either mock-treated or treated with RNAse A. The lysates
were then fractionated on 5–50% sucrose gradients and 20 fractions
were collected for further analysis by western blotting for viral and host
proteins, as indicated. HIV-1 viral genomic RNA (vRNA, 9 kb) was
assessed in each fraction by slot blot analysis. TL represents the total
lysates. (B) HeLa cells were co-transfected with pNL 4–3 and
Staufen1-HA. The presence of Staufen1-HA, precursor Gag and p24 were
assessed in each fraction by western blotting analysis. HIV-1 viral
genomic RNA (9 kb, vRNA) was assessed in each fraction by slot blot
analysis. Staufen1, Gag and vRNA were quantitated in each fraction by
densitometry and relative levels are depicted for each fraction (Blue:
Staufen1-HA, Red: Gag, Green-vRNA).
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processed form of Gag,p24,which likely represents capsids or virus
particles that are membrane-bound (Levesque et al., 2006). The
precursor to p24,p25 was also observed in the lighter fractions sup-
porting this notion (Figure 5 and below). We have shown that the
Staufen1-Gag interaction is RNA-independent and in close prox-
imity (Chatel-Chaix et al., 2004) so these results indicate that Gag is
recruited to pre-existing Staufen1 RNPs as we demonstrated earlier
(Milev et al., 2010) but also, it remains associated to Staufen1 when
viral and cellular RNAs are in limiting supply. This notion is also
supported in experiments in which a Gag-less pNL4-3 is expressed.
This proviral DNA will express all viral proteins and RNAs except
for Gag and Gag/Pol (Poon et al., 2002). When expressed alone
(Figure 6A) or when Staufen1-HA is overexpressed (Figure 6B),
the sedimentation profiles for vRNA were not appreciably affected
in the absence of Gag. This is consistent with our recent findings
that showed that Staufen1 and vRNA co-localized significantly
in the absence of Gag under the same experimental conditions
(Abrahamyan et al., 2010). When Gag expression was rescued by
the expression of a Rev-dependent Gag expressor (Lingappa et al.,
2006; Figure 6C), the distribution of vRNA was consistently found
to be shifted toward the lighter fractions, that might be specific
to this rescue experiment (i.e., due to trans expression of Gag)
because the vRNA is found in the penultimate fractions when
pNL4-3 is expressed (Figure 5). Further experimentation will be
required to characterize the function of these lighter RNPs upon
Gag rescue in trans.
In the experiments above, endogenous Staufen1 is abundantly
expressed that could allow the assembly of Staufen1 viral RNPs.
In conditions when endogenous Staufen1 is depleted by siRNA,
we have shown that large Staufen1 RNPs (SHRNPs) formed in the
vicinity of the nucleus and in the cytoplasm. These structures were
proposed to be supraphysiologic RNPs that could serve as scaf-
folds for viral assembly and vRNA encapsidation. We investigated
by density gradient analysis whether the SHRNPs represented
a super-dense RNP or amalgamations of many smaller RNPs.
HeLa cells were transfected with pNL4-3 DNA and either siNS or
siStaufen1 siRNAs and lysates were prepared for gradient analyses.
While siStaufen1 treatment again resulted in reduced Gag synthesis
(Abrahamyan et al., 2010; Figure 7A), the sedimentation profiles
for vRNA and Gag did not appreciably change (Figures 7B,C).
However, the relative levels of Gag in light and dense gradient frac-
tions were modulated such that a less abundant signal for Gag in
the dense fractions was observed. This could be the populations of
Gag influenced by Staufen1 expression levels and functionally rel-
evant for the assembly of dense RNPs or represent a population of
Gag with a specific function (Klein et al., 2007). Importantly, these
results provide evidence that the larger Staufen1 RNPs observed
in Staufen1 depletion conditions likely represent aggregations of
FIGURE 6 |The sedimentation of Staufen1 and vRNA
indensitygradientsdid not significantly change in the absence of Gag
expression. (A) HeLa cells were co-transfected with pNL4-XX (harboring two
mutations in the gag open reading frame to prevent Gag synthesis) with
either empty vector control (A), Staufen1-HA (B), or Gag-RRE (C). The cells
lysates were then fractionated on 5–50% sucrose gradients and 20 fractions
were collected for further analysis by western blotting analyses, as indicated.
TL represents the total lysates. Staufen1, Gag and vRNA were quantitated in
each fraction by densitometry and relative levels are depicted for each fraction
(Blue: Staufen1-HA, Red: Gag, Green: vRNA).
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FIGURE 7 |The relative levels of Gag in light and dense gradient
fractions are modulatedin Staufen1-depleted cells. HeLa cells were
mock transfected or co-transfected with pNL4-3 with either
non-silencing control siRNA (siNS) or a siRNA to deplete endogenous
Staufen1 (siStaufen1) and were harvested and lysed 36 h later and
analyzed by western blotting. Corresponding expression levels for
Staufen1, Gag, UPF1 and GAPDH proteins are shown in (A). The cell
lysates from siNS-treated (B) and siStaufen1-treated (C) cells were
fractionated on 5–50% sucrose gradients and 19–20 fractions were
collected for further analysis by western blotting, as indicated. TL
represents the total lysates. HIV-1 viral genomic RNA (9 kb, vRNA) was
assessed in each fraction by slot blot analysis. Staufen1, Gag and vRNA
were quantitated in each fraction by densitometry and relative levels are
depicted for each fraction (Blue: Staufen1-HA, Red: Gag, Green: vRNA).
similar-sized RNPs rather than the assembly of a supraphysiologic
RNP (Abrahamyan et al., 2010).
DISCUSSION
The combination of TAP and mass spectrometry has proven to
be reliable for the characterization of different protein complexes
(reviewed in Xu et al., 2010) including those containing HIV-1
Gag, UPF1 and Staufen1 (Schell et al., 2003; Brendel et al., 2004;
Villace et al., 2004; Roy et al., 2006). Here we provide deeper
insights into the impact of HIV-1 expression on the composition
of Staufen1 RNPs.
While the analyses performed here detected almost all of the
previously characterized proteins characterized as components of
Staufen1 RNPs (Brendel et al., 2004; Villace et al., 2004), they
also revealed that the protein composition of the particles was
influenced by the presence of HIV-1. In addition to the viral gene
products, Gag, Gag/Pol, Env and Nef, which are all incorporated
into Staufen1 RNPs in the presence of HIV-1, generally the num-
ber of proteins in the Staufen1 RNP was enhanced in the presence
of HIV-1 (Figure 3; Table 1; Tables S1 and S2 in Supplementary
Material). In addition,HIV-1-mediated an increase in the amounts
of several other host proteins that were found in smaller amounts
in Staufen1-containing RNPs isolated from uninfected 293T cells
(Figure 2A). The signal intensities of UPF1, eF1α, ribosomal pro-
tein L7a and RHA, for example, were approximately threefold
greater in western blotting experiments in the presence of HIV-
1. Endogenous Staufen1 was also recruited to a higher degree to
the complexes isolated from HIV-1-expressing cells (Figure 2A,
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top panels). This HIV-1-mediated modulation in protein com-
position of the Staufen1 RNA was indeed selective since equal
quantities of several other proteins, such as IMP1, ABCE1 and
UPF3 were found between the two treatment groups. The changes
to the Staufen1 protein environment described here could invari-
ably be mediated by the presence of the four viral proteins (Gag,
Gag/Pol, Env and Nef) and the vRNA within the Staufen1 HIV-1
RNP, thereby recruiting and enriching for a number of host fac-
tors. Consistently, Gag can recruit Staufen1 and other host factors
(Milev et al., 2010). When this analysis was performed in Jurkat
T cell lines, we did not observe some of the same changes to the
abundance of proteins (e.g., TDP-43) as judged in western blots
(Figure 2C). This could possibly be due to lower transfection effi-
ciencies, or more likely, because the compactness of the cytoplasm
in Jurkat T cells and the relatively shorter intracellular distances
in these mononuclear cells might restrict the protein content of
Staufen1 RNPs in general. Overall, it will be important to ana-
lyze further the possible functions of the unique proteins found in
Staufen1 HIV-1 RNPs and their effects on HIV-1 replication.
CONSTITUENTS OF STAUFEN1 RNPs INVOLVED IN mRNA
TRANSLATION, TRAFFICKING AND STABILITY
We identified numerous Staufen1-associated proteins including
the small and large ribosomal subunit proteins, translation initia-
tion and elongation factors, tRNA synthetases, some of which are
involved in RNA trafficking RNPs (Carson et al., 2008). Most of
these proteins were common components that were identified in
both native Staufen1 and Staufen1 HIV-1 RNPs as it was in the
cases of eIF3α and eIF4A1 (Tables S1 and S2 in Supplementary
Material). However, eIF3β was only found in native and eIF3ε was
only detected in Staufen1 HIV-1 RNPs (Table 1; Tables S1 and S2
in Supplementary Material). In the context of the Staufen1 HIV-1
RNPs, their functions in mRNA translation could be potentially
enhanced by the presence of the viral proteins and evidence for
this is supported in the literature (Jager et al., 2012). For example,
Env, influences RPS6 kinase and upregulates mRNA translation
(Barcova et al., 1999). Furthermore, HIV-1 Gag and that of other
retroviruses can modulate the translation activity of its cognate
mRNA (the vRNA; Sonstegard and Hackett, 1996; Anderson and
Lever, 2006).
Proteins involved in mRNA stability were also common to
both native Staufen1 and Staufen1 HIV-1 RNPs including Upf1,
Upf3b, IMP1 and FUSE-binding protein (refer to Tables S1 and
S2 in Supplementary Material for others), but IMP2 and IMP3
were exclusive to native and to Staufen1 HIV-1 complexes, respec-
tively. Although several of these factors have already been shown
to alter HIV-1 gene expression (Ajamian et al., 2008; Zhou et al.,
2008), additional work will be needed to determine their roles
in Staufen1-containing RNPs. Nevertheless, the presence of these
proteins suggests that Staufen1 RNPs are involved in the regula-
tion of mRNA translation and stability of both cellular and viral
mRNAs. Many components identified as constituents of stress
granules (Ohn et al., 2008) were also observed in Staufen1 RNPs
including Staufen1 itself, several RNA helicases, translation factors
(eIF3, eEF1), IMP1 and ribosomal proteins (Table S2 in Supple-
mentary Material) and their presence or sequestration could be
implicated in the abrogation of this stress response in HIV-1- and
other virus-infected cells (Abrahamyan et al., 2010; Ruggieri et al.,
2012).
STAUFEN1 RNPs: IMPLICATIONS IN TRANSCRIPTION, SPLICING AND
mRNA NUCLEAR RETENTION?
Staufen1 RNP also contain a number of proteins implicated in
nuclear RNA quality control, a role we have previously char-
acterized for UPF1 (Ajamian et al., 2008). We detected several
predominantly nuclear proteins in native Staufen1 and Staufen1
HIV-1 RNPs such as nucleolin (NCL), hnRNPU and RNA heli-
case (RHA or DDX9; Brendel et al., 2004; Villace et al., 2004) and
several transcription and splicing factors as common elements in
both control and HIV-1 Staufen1 RNPs (Tables S1 and S2 in Sup-
plementary Material), but there were also significant differences.
Staufen1 HIV-1 RNPs appeared to be enriched in splicing factors,
RNA helicases and hnRNPs (refer to Table 1) that are specifically
co-opted by HIV-1 and have established roles in HIV-1 replica-
tion (Caputi et al., 1999; Jeang and Yedavalli, 2006; Levesque et al.,
2006; Lund et al., 2012). The NF-κB repressing factor (NRF), for
instance, binds to a specific negative regulatory element within
the HIV-1 LTR and regulates transcription initiation and elonga-
tion (Dreikhausen et al., 2005). Two other RNA- and DNA-binding
proteins SFPQ (PSF) and Non-POU domain-containing octamer-
binding protein (NONO) act in the context of a heterodimer and
play essential roles in the transcriptional regulation and in the
pre-mRNA splicing. As well, both proteins play a role in HIV-
1 replication by binding, with high affinity, the instability (INS)
regions in HIV-1 gag mRNA suggesting a role in RNA stabil-
ity or translation (Zolotukhin et al., 2003). Importantly, NONO
and PSF form a complex with another common Staufen1 compo-
nent, nuclear matrix protein Matrin 3, as described above (Zhang
and Carmichael, 2001; DeCerbo and Carmichael, 2005). Since
Staufen1 can shuttle between the nucleus and cytoplasm (Martel
et al., 2006), these potential associations represent potential ther-
apeutic targets in the context of the transporting Staufen1 RNP.
STAUFEN1 RNPs FACTORS INVOLVED IN GENERAL METABOLISM AND
CHOLESTEROL BIOGENESIS
Surprisingly and exclusive to Staufen1 HIV-1 RNPs, we detected
phosphatidylserine synthase 1 (PTDSS1), long-chain-fatty-acid-
CoA ligase 3 (ACSL3) and 7-dehydrocholesterol reductase
(DHCR7), the latter catalyzing the generation of cholesterol
(Table 1). Gag’s interaction with Staufen1 on cholesterol-rich
membranes could suggest a functional implication in cellular cho-
lesterol biogenesis (Milev et al., 2010) in that rerouting cholesterol-
rich membranes toward the periphery promotes virus release and
infectivity (Liao et al., 2001; Tang et al., 2009; Coleman et al., 2012).
Likewise, Nef was also detected in Staufen1 HIV-1 RNPs and this
viral protein could also influence assembly and trafficking since
it induces cholesterol biosynthesis genes (Table 1; Zheng et al.,
2003; van’t Wout et al., 2005). These findings favor the idea that
the processes of cholesterol biosynthesis, the formation of lipid
rafts and the trafficking of viral components might be associated
to Staufen1-containing complexes.
STAUFEN1-BINDING PARTNERS INVOLVED IN VESICULAR TRAFFICKING
We identified multiple proteins that regulate vesicle biogenesis
and trafficking within Staufen1 RNPs (±HIV-1), with twice the
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number of proteins with related functions when HIV-1 was
expressed. Several common components were detected and known
to be involved in the intracellular vesicular transport between the
plasma membrane, endoplasmic reticulum and Golgi membranes
including the coatomer subunit alpha (COPA; Beck et al., 2009),
vesicle-fusing ATPase (NSF; Zhao et al., 2007) and adaptor protein
AP-3S1 (sigma subunit; Tables S1 and S2 in Supplementary Mate-
rial). The coatomer subunit zeta-1 (COPZ1), ADP-ribosylation
factors ARF4 and ARF6, several Rab-related proteins (Rab-5C, -8A
and -10), adaptor proteins AP-2M1 (mu subunit), AP-3D1 (delta
subunit), which importantly, interact with Nef and Env (i.e., AP-2,
mu; Boge et al., 1998; Craig et al., 2000) and Gag (i.e., AP-2, mu;
AP-3, delta; Batonick et al., 2005; Dong et al., 2005) all uniquely
associated to the Staufen1 HIV-1 RNPs (Table 1). We also iden-
tified a putative YXXØ (where Ø is a bulky hydrophobic residue)
sorting signal in the dsRBD3 of Staufen1 (similar to that found
in both Gag and Env; Batonick et al., 2005) that may mediate the
mu subunit binding. Likewise, the existence of several di-leucine
sorting motifs in Staufen1 could mediate binding to COP1 beta
(Ohno et al., 1995; Rapoport et al., 1998). These observations sup-
port the notion that the mRNA/HIV-1 vRNA transport pathways
are coupled with organized vesicular trafficking in cells (Cohen,
2005; Baumann et al., 2012), that is strengthened by several recent
observations that vRNA traffics on endosomal membranes during
HIV-1 egress and assembly (Lehmann et al., 2009; Molle et al.,
2009).
Most of the biochemical evidence points to a role for Staufen1
RNPs in vRNA fate. The co-sedimentation of several compo-
nents with Staufen1, using the available antibodies, reveals co-
associations that are likely to be functionally relevant in this
context and important for HIV-1-mediated disease (e.g., Tosar
et al., 2012). Indeed, several of these associations have been charac-
terized previously, for example those that have been characterized
between Gag and ABCE1, Staufen1, UPF1, AUF1, IMP1 and RNA
helicases. These RNPs appear to be static in size (Figure 6), but
are mobile since they can aggregate in clusters when Staufen1 is
in limiting supply (Abrahamyan et al., 2010). The disruption of
all of these protein complexes upon RNAse A treatment reveals
the dependence on viral and/or cellular RNA but also indicates
that the targeting of RNA-related phenomena will be a suitable
therapeutic approach in the future (Radi et al., 2012).
CONCLUSION
Staufen1 has multiple roles during HIV-1 replication including
one in Gag multimerization and another in genomic RNA encap-
sidation. The present study applied tandem affinity immuno-
purification techniques coupled with mass spectrometry to char-
acterize the composition of Staufen1 RNPs in HIV-1-expressing
cells. Our results demonstrate that HIV-1 induces substantial
changes to the composition of cellular Staufen1 RNPs. The identi-
fication of the associated host and viral factors to the Staufen1 RNP
will contribute to a better understanding of how HIV-1 co-opts
subcellular RNPs and machineries to achieve intracellular traffick-
ing, efficient gene expression and the correct localization and fate
of its genomic RNA.
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